{"schemaVersion":"peptidescanner-peptide-evidence-feed/v1","canonicalUrl":"https://peptidescanner.com/feeds/peptides/cerebrolysin.json","peptide":{"slug":"cerebrolysin","name":"Cerebrolysin","url":"https://peptidescanner.com/peptides/cerebrolysin/"},"release":{"label":"Beta · 17 Nov 2026","reviewedAt":"2026-11-17"},"entryCount":47,"entries":[{"objectId":"story:pubmed-pmid-43030876-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-17","title":"Longitudinal Serum and Cerebrospinal Fluid S100B Concentrations After Aneurysmal Subarachnoid Hemorrhage: An Exploratory Comparison of Historical Cohorts With and Without Cerebrolysin Exposure.","domain":"Literature metadata","dateInSource":"2026-11-14","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-43030876-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-43030876-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-43030876-cerebrolysin-v1","contentSha256":"17cc53bbba942f45adb45fea7c4de4f8603492bd8d47a66fbd7a995186ad956c"},{"objectId":"story:clinicaltrials-gov-nct00840671-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00840671","domain":"Clinical trials","dateInSource":"2010-12-28","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00840671-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct00840671-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct00840671-cerebrolysin-v1","contentSha256":"3d9e4a714c02111ca6d452c9dd91413f0cee232e4468dcd93ab10e2fec7d09df"},{"objectId":"story:clinicaltrials-gov-nct00868283-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00868283","domain":"Clinical trials","dateInSource":"2023-12-15","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00868283-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct00868283-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct00868283-cerebrolysin-v1","contentSha256":"a698eba4cce7ae482c8180e43175d18c395e12498a7e0c59c37f6fe061415db4"},{"objectId":"story:clinicaltrials-gov-nct00947531-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00947531","domain":"Clinical trials","dateInSource":"2024-02-21","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00947531-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct00947531-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct00947531-cerebrolysin-v1","contentSha256":"05fd462a25dbd35d4ff9bce33ca8ddd031f9463c30baf6b411a47eb29e26d059"},{"objectId":"story:clinicaltrials-gov-nct01059461-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT01059461","domain":"Clinical trials","dateInSource":"2013-09-13","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01059461-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct01059461-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct01059461-cerebrolysin-v1","contentSha256":"08b0bba77d932629dac2d3bd72813fd24480dbe5e6c4a28d4b7732549186ccdc"},{"objectId":"story:clinicaltrials-gov-nct01388738-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT01388738","domain":"Clinical trials","dateInSource":"2011-12-23","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01388738-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct01388738-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct01388738-cerebrolysin-v1","contentSha256":"954da19595be3e9f93c04abd70d3da63fe3d35881bef8246a92679140ae0ff6b"},{"objectId":"story:clinicaltrials-gov-nct02149875-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT02149875","domain":"Clinical trials","dateInSource":"2020-08-24","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02149875-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct02149875-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct02149875-cerebrolysin-v1","contentSha256":"9373fc0a1cfe982d381915f372c978b60e2bae27d1fa4461d921e0b9e16ab1e3"},{"objectId":"story:clinicaltrials-gov-nct02768571-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT02768571","domain":"Clinical trials","dateInSource":"2019-09-20","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02768571-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct02768571-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct02768571-cerebrolysin-v1","contentSha256":"aefbd9f63839ba268c3af836db189d87ec981b5d531c718d3914ad32585fd767"},{"objectId":"story:clinicaltrials-gov-nct03480698-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT03480698","domain":"Clinical trials","dateInSource":"2025-02-25","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03480698-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct03480698-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct03480698-cerebrolysin-v1","contentSha256":"47b56ab30582111485d2882ee58674c7a6d01fa0101cbd4242490e4b512f318a"},{"objectId":"story:clinicaltrials-gov-nct03506841-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT03506841","domain":"Clinical trials","dateInSource":"2021-03-15","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03506841-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct03506841-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct03506841-cerebrolysin-v1","contentSha256":"6ee563ad0e0215a724a9c071eaf0b37f495ac13facd7aafceccf0bdb5f288524"},{"objectId":"story:clinicaltrials-gov-nct04427241-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT04427241","domain":"Clinical trials","dateInSource":"2026-05-11","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04427241-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct04427241-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct04427241-cerebrolysin-v1","contentSha256":"22a2623793c97242f1eb2e1473052d89734786117e5a09f03fef88ad4ebfb2c6"},{"objectId":"story:clinicaltrials-gov-nct04751136-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT04751136","domain":"Clinical trials","dateInSource":"2021-02-11","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04751136-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct04751136-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct04751136-cerebrolysin-v1","contentSha256":"e2c95b91c5430aa9802d4b3aba28279c1d0870074aacffff42dbb88d667e6f6e"},{"objectId":"story:clinicaltrials-gov-nct04830943-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT04830943","domain":"Clinical trials","dateInSource":"2023-01-03","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04830943-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct04830943-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct04830943-cerebrolysin-v1","contentSha256":"aa0858210b30aa23e1fbeedd2b49c4957fe44fbd2ceb57aa4eac641d3e50425b"},{"objectId":"story:clinicaltrials-gov-nct05288465-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT05288465","domain":"Clinical trials","dateInSource":"2022-03-21","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05288465-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct05288465-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct05288465-cerebrolysin-v1","contentSha256":"bac106067f247eaa006b23ed65da05aed923999079b1b81d285f51458b16a4bf"},{"objectId":"story:clinicaltrials-gov-nct05755997-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT05755997","domain":"Clinical trials","dateInSource":"2025-02-25","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05755997-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct05755997-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct05755997-cerebrolysin-v1","contentSha256":"c93fd501d37a2eaa04f7ab018d6d9d2ea199f8000c1e6397b74d0325dcf4d436"},{"objectId":"story:clinicaltrials-gov-nct05807503-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT05807503","domain":"Clinical trials","dateInSource":"2023-04-11","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05807503-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct05807503-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct05807503-cerebrolysin-v1","contentSha256":"7235aa47a336280dd6f33300110c323c7209ca46dad74f9c23f2efcb9119ea66"},{"objectId":"story:clinicaltrials-gov-nct05821075-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT05821075","domain":"Clinical trials","dateInSource":"2025-07-31","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05821075-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct05821075-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct05821075-cerebrolysin-v1","contentSha256":"e53e18ad4ba3263ee0b6dd03a2628e9369bc14b5ab45a1d1897d2d73a67bbc48"},{"objectId":"story:clinicaltrials-gov-nct06052787-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT06052787","domain":"Clinical trials","dateInSource":"2025-11-19","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06052787-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct06052787-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct06052787-cerebrolysin-v1","contentSha256":"8c01b47def8f68e7372f21f5001a6c8cd1b089b52cbc07f9bd0f8ba1feee3712"},{"objectId":"story:clinicaltrials-gov-nct06208540-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT06208540","domain":"Clinical trials","dateInSource":"2024-08-05","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06208540-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct06208540-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct06208540-cerebrolysin-v1","contentSha256":"076feacb2dd204d6d02ce5189cc490215b26daf151f3f8ef832dbe64b1000a36"},{"objectId":"story:clinicaltrials-gov-nct06339411-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT06339411","domain":"Clinical trials","dateInSource":"2026-08-11","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06339411-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct06339411-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct06339411-cerebrolysin-v1","contentSha256":"654c7700a565a27ed0a0cd736776a2eacd4831cb24c25c028ae6920a8e8bb8ef"},{"objectId":"story:clinicaltrials-gov-nct06677502-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT06677502","domain":"Clinical trials","dateInSource":"2024-12-31","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06677502-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct06677502-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct06677502-cerebrolysin-v1","contentSha256":"2ee564fe41a56c7071ebecb7aff5f8e6cf8096d060216801f45010515a986dbc"},{"objectId":"story:clinicaltrials-gov-nct07846488-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT07846488","domain":"Clinical trials","dateInSource":"2026-09-29","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07846488-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#clinicaltrials-gov-nct07846488-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#clinicaltrials-gov-nct07846488-cerebrolysin-v1","contentSha256":"72976f82c0aba82262f79685c5bdfdd12907f10b83e944aa9128ab334c93954b"},{"objectId":"story:pubmed-pmid-11738849-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Cerebrolysin therapy in Rett syndrome: clinical and EEG mapping study.","domain":"Literature metadata","dateInSource":"2022-03-31","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-11738849-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-11738849-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-11738849-cerebrolysin-v1","contentSha256":"3b30d4d3cf806b6a4b09872437e21797d1eb277aa6fcf483f2bfaca5d8436cdd"},{"objectId":"story:pubmed-pmid-19848437-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Cerebrolysin: a review of its use in dementia.","domain":"Literature metadata","dateInSource":"2026-10-11","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-19848437-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-19848437-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-19848437-cerebrolysin-v1","contentSha256":"3d96e9297ded94f1d5a4bc4c3c1d1887cf7ee8446c689aca7431aa893b2108ac"},{"objectId":"story:pubmed-pmid-20393954-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Cerebrolysin for acute ischaemic stroke.","domain":"Literature metadata","dateInSource":"2025-06-26","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-20393954-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-20393954-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-20393954-cerebrolysin-v1","contentSha256":"d1f7b03b0b49f2b61307189809a1834c1e42324f5f15f7064f05325719cd7c7d"},{"objectId":"story:pubmed-pmid-21350421-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"[Efficiency of cerebrolysin in the diabetic polyneuropathy in patients with insulin-dependency diabetes mellitus].","domain":"Literature metadata","dateInSource":"2016-11-25","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-21350421-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-21350421-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-21350421-cerebrolysin-v1","contentSha256":"d2c591b1880f79ed77f8310858f4651ea8fe0a6644e67e7161f11dc9e41e8184"},{"objectId":"story:pubmed-pmid-23440834-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Cerebrolysin for vascular dementia.","domain":"Literature metadata","dateInSource":"2025-07-11","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23440834-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-23440834-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-23440834-cerebrolysin-v1","contentSha256":"12a6881466ab099e4f68aa686cda6a51a0f57196e5bec656bf59ccca8236883b"},{"objectId":"story:pubmed-pmid-23805635-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"[Cerebrolysin for acute ischemic stroke].","domain":"Literature metadata","dateInSource":"2026-04-27","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23805635-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-23805635-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-23805635-cerebrolysin-v1","contentSha256":"a89514a316ec7f14cf48a9bd3a78311bc878dc73d9dd0f1e1dd48f15937d863d"},{"objectId":"story:pubmed-pmid-24730284-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"The role of functionalized magnetic iron oxide nanoparticles in the central nervous system injury and repair: new potentials for neuroprotection with Cerebrolysin therapy.","domain":"Literature metadata","dateInSource":"2019-07-15","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-24730284-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-24730284-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-24730284-cerebrolysin-v1","contentSha256":"81619039b26be8ad5d9a6404f5dbf7ca9a4a4b24ad4747084405f6724e277b6f"},{"objectId":"story:pubmed-pmid-25591645-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"[Cerebrolysin in the treatment of brain injuries of moderate severity].","domain":"Literature metadata","dateInSource":"2016-11-25","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-25591645-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-25591645-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-25591645-cerebrolysin-v1","contentSha256":"a751185deaa46e1878e0d4db16b2e99b21567aad71483a2366d42ca9c04d572f"},{"objectId":"story:pubmed-pmid-26083192-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Cerebrolysin for acute ischaemic stroke.","domain":"Literature metadata","dateInSource":"2025-07-11","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-26083192-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-26083192-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-26083192-cerebrolysin-v1","contentSha256":"8bc2a4d7c8afb4fe32bbf300b06b7bca4697542e42b365983538b9bb2635c41e"},{"objectId":"story:pubmed-pmid-27918088-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Cerebrolysin for acute ischaemic stroke.","domain":"Literature metadata","dateInSource":"2025-06-26","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-27918088-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-27918088-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-27918088-cerebrolysin-v1","contentSha256":"eaa81a3330a0fefa7c1547d4b6be530abacab1396dd03be066d4402ecaa1f3ef"},{"objectId":"story:pubmed-pmid-28430363-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Cerebrolysin for acute ischaemic stroke.","domain":"Literature metadata","dateInSource":"2025-06-23","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-28430363-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-28430363-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-28430363-cerebrolysin-v1","contentSha256":"c21ae578dfb4b89317ffa42fbc93c6f04204ccca35e834eb78979cc3846a022a"},{"objectId":"story:pubmed-pmid-29155000-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Role of Cerebrolysin in cervical spondylotic myelopathy patients: a prospective randomized study.","domain":"Literature metadata","dateInSource":"2019-02-21","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-29155000-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-29155000-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-29155000-cerebrolysin-v1","contentSha256":"d40927bb5d97d5ec404f3623958e996b48e239cfac053766ec151583b7fdecf0"},{"objectId":"story:pubmed-pmid-30004268-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Cerebrolysin: a multi-target drug for recovery after stroke.","domain":"Literature metadata","dateInSource":"2019-05-09","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-30004268-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-30004268-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-30004268-cerebrolysin-v1","contentSha256":"fb7b9fd856cd8ce75c2e11a3f84cfeb348ed92701fcc00da71cc8469ff1e0be8"},{"objectId":"story:pubmed-pmid-31710397-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Cerebrolysin for vascular dementia.","domain":"Literature metadata","dateInSource":"2024-09-02","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-31710397-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-31710397-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-31710397-cerebrolysin-v1","contentSha256":"e0b2a7c42e5a743c25b2e33a172d2f32124ee387811bc4c48a271ab85fffc921"},{"objectId":"story:pubmed-pmid-32662068-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Cerebrolysin for acute ischaemic stroke.","domain":"Literature metadata","dateInSource":"2025-05-30","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-32662068-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-32662068-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-32662068-cerebrolysin-v1","contentSha256":"3ffbad3c45473c1e0865572607d59f6ca8d039342ecaa5ce2a179b2927c608b9"},{"objectId":"story:pubmed-pmid-32808294-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use.","domain":"Literature metadata","dateInSource":"2021-10-28","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-32808294-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-32808294-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-32808294-cerebrolysin-v1","contentSha256":"067c2acab3457dda1e4ab48b35968756f8d33a904976c0379c4983ac2fb0495f"},{"objectId":"story:pubmed-pmid-33223037-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Diabetes exacerbates brain pathology following a focal blast brain injury: New role of a multimodal drug cerebrolysin and nanomedicine.","domain":"Literature metadata","dateInSource":"2021-11-24","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-33223037-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-33223037-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-33223037-cerebrolysin-v1","contentSha256":"8653adee259a4559b378a81b0bd00f4b24b034d82d816c30a28e3c55b079cfe1"},{"objectId":"story:pubmed-pmid-33620612-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Cerebrolysin after moderate to severe traumatic brain injury: prospective meta-analysis of the CAPTAIN trial series.","domain":"Literature metadata","dateInSource":"2026-10-10","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-33620612-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-33620612-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-33620612-cerebrolysin-v1","contentSha256":"40a0ac944333c696e779cafb8c3fb23e00977c54e80ef3954b40136121e74012"},{"objectId":"story:pubmed-pmid-36979317-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis.","domain":"Literature metadata","dateInSource":"2023-03-31","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-36979317-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-36979317-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-36979317-cerebrolysin-v1","contentSha256":"193546e3ed24c49e086f93aecb7967e25aec08a787824da2fc392e18eafafbd9"},{"objectId":"story:pubmed-pmid-37522695-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Noninvasive monitoring in a patient with SAH diagnosis treated with Cerebrolysin - case report and review of the literature.","domain":"Literature metadata","dateInSource":"2023-08-21","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-37522695-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-37522695-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-37522695-cerebrolysin-v1","contentSha256":"fc3d631d64a2969cc9c4e97595617400caa552332b8d96e03f8c18b39758f003"},{"objectId":"story:pubmed-pmid-37818733-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Cerebrolysin for acute ischaemic stroke.","domain":"Literature metadata","dateInSource":"2025-06-26","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-37818733-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-37818733-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-37818733-cerebrolysin-v1","contentSha256":"f849bd9873526fb87fe4981392f9215628df6ed8092c2370e51afdf2d6a1c421"},{"objectId":"story:pubmed-pmid-37892776-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Cerebrolysin in Patients with Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis.","domain":"Literature metadata","dateInSource":"2026-09-21","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-37892776-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-37892776-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-37892776-cerebrolysin-v1","contentSha256":"ba7913e225f5d0e834706204aaa8f91b7da161fcb48624982671beb7635c67ab"},{"objectId":"story:pubmed-pmid-39832667-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts.","domain":"Literature metadata","dateInSource":"2026-06-07","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39832667-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-39832667-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-39832667-cerebrolysin-v1","contentSha256":"82f7445ae2bc7927dc6667b74a708c5106bdfe00af859f8f8ec79a3e63e2d451"},{"objectId":"story:pubmed-pmid-40577185-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"[Cerebrolysin with reperfusion therapy in ischemic stroke: a prospective analysis of multimodal brain imaging data from the CEREHETIS trial].","domain":"Literature metadata","dateInSource":"2025-07-03","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-40577185-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-40577185-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-40577185-cerebrolysin-v1","contentSha256":"3c8dfd76eec9c6eb9f6f89ef833ff98cb957076685d2a79d8ad4fb392aa31a7e"},{"objectId":"story:pubmed-pmid-41349847-cerebrolysin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Cerebroprotection in acute ischemic stroke: Perspectives on combining cerebrolysin with recanalization therapy.","domain":"Literature metadata","dateInSource":"2026-01-10","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-41349847-cerebrolysin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.json#pubmed-pmid-41349847-cerebrolysin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cerebrolysin.md#pubmed-pmid-41349847-cerebrolysin-v1","contentSha256":"157a7659a18204a4e3a114a8bc8897402dbccf00f8fdc079df9e32d8de8df684"}]}
